Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tougeron

Showing results (81-90 of 235) with videos related to

Pageof 24
Sort By:
British Journal of Cancer|February 12, 2022
Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
British Journal of Cancer|January 30, 2022
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
Helicobacter|July 24, 2020
A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence areaNicolas Chapelle, Pawel Petryszyn, Justine Blin, et al.
Journal of Clinical Medicine|September 4, 2020
Where to Biopsy to Detect <i>Helicobacter pylori</i> and How Many Biopsies Are Needed to Detect Antibiotic Resistance in a Human StomachMaxime Pichon, Cong Tri Tran, Gaëtan Motillon, et al.
BMC Cancer|July 9, 2016
Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use programAntoine Adenis, Christelle de la Fouchardiere, Bernard Paule, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 20, 2019
Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Jean Marc Phelip, David Tougeron, David Léonard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance)Harry H Yoon, David Tougeron, Qian Shi, et al.
Journal of Neuro-Oncology|January 3, 2025
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factorsViolaine Randrian, Fabienne Portales, Olivier Bouché, et al.
BMC Cancer|July 27, 2016
Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use programAntoine Adenis, Christelle de la Fouchardiere, Bernard Paule, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2016
Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre studyBertrand Brieau, Claire Auzolle, Astrid Pozet, et al.
Pageof 24

Showing results (81-90 of 235) with videos related to

Sort By:
Pageof 24
British Journal of Cancer|February 12, 2022
Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
British Journal of Cancer|January 30, 2022
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
Helicobacter|July 24, 2020
A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence areaNicolas Chapelle, Pawel Petryszyn, Justine Blin, et al.
Journal of Clinical Medicine|September 4, 2020
Where to Biopsy to Detect <i>Helicobacter pylori</i> and How Many Biopsies Are Needed to Detect Antibiotic Resistance in a Human StomachMaxime Pichon, Cong Tri Tran, Gaëtan Motillon, et al.
BMC Cancer|July 9, 2016
Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use programAntoine Adenis, Christelle de la Fouchardiere, Bernard Paule, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 20, 2019
Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Jean Marc Phelip, David Tougeron, David Léonard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance)Harry H Yoon, David Tougeron, Qian Shi, et al.
Journal of Neuro-Oncology|January 3, 2025
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factorsViolaine Randrian, Fabienne Portales, Olivier Bouché, et al.
BMC Cancer|July 27, 2016
Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use programAntoine Adenis, Christelle de la Fouchardiere, Bernard Paule, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2016
Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre studyBertrand Brieau, Claire Auzolle, Astrid Pozet, et al.
Pageof 24